ST Biosciences

ST Biosciences is a global biotech company that specializes in the research, development, cultivation, processing, and commercialization of pharmaceutical and medicinal cannabis products. The company prides itself on setting the global standard in Cannabis Life Science through the creation of innovative cannabis-based pharmaceutical, nutraceutical, and medicinal products, as well as the establishment of state-of-the-art cannabis cultivation facilities. Founded in 2012, ST Biosciences has made its mark in 31 markets worldwide, including the U.S., South America, Europe, and Asia. As a fully vertical company, ST Biosciences controls the entire product life cycle chain, from genetics development to distribution, maintaining the highest industry standards with facilities that meet GMP, GAP, and ISO certification. This approach ensures consistent product quality and grants the company a significant advantage in the global marketplace. With a firm belief in the transformative power of CBD and TJC, ST Biosciences is uniquely positioned to leverage its expertise and global presence to deliver on its promises.